Page results
-
Online talk on diet for people having cancer care at UCLH
-
Online workshop for people having care for cancer or a blood condition at University College London Hospitals
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
-
Diet and nutrition advice for people experiencing weight loss, weight gain, appetite changes, difficulty eating, or other digestive problems which have happened as a result of their treatment or condition. Advice is also available for people who are confused about what diet or nutrition advice to follow.
-
Advice for University College London Hospital patients who have experienced hair loss.
-
This page is for patients having planned neurosurgery.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided joint and soft tissue injections to patients referred by the Camden community MSK services.
-
This page is for patients who are receiving radiotherapy to the bladder.
-
This page gives advice for those wanting to refer patients for nuclear medicine investigations at University College London Hospitals NHS Foundation Trust. Given at the end of this page are appropriate referral guidelines for the tests we perform.
-
Patient information for patients undergoing Image Rehearsal Therapy (IRT).
File results
-
FOI2017266 Viscosupplementation injections
-
FOI2017263 Self-administration of medicines policies and carers policies
-
FOI2017295 A&E attendances for acopia
-
FOI2017296 Contracts for the redevelopment of the Middlesex annexe and Royal London Hospital for Integrated Medicine
-
FOI2017307 Televisions for patients
-
FOI2017314 Deep brain stimulation procedures
-
FOI2017300 Sustainability and transformation
-
FOI2017315 Expenditure on reconciliation and validation of incomplete and missing RTT codes
-
FOI2017320 Patients with Multiple Sclerosis treated with MS disease modifying drugs
-
FOI/2023/0226 - Treatment with Nivolumab